It is therefore not surprising that the ectopic expression of IL-6 or treatment with recombinant IL-6 in ER+ breast cancer cells significantly increases the expression of EMT-related genes through STAT3, leading to increases in tumor cell proliferation in orthotopic xenograft models [135]. The gene discussed is IL6; the disease is breast carcinoma.